Form 8-K - Current report:
SEC Accession No. 0001193125-24-235955
Filing Date
2024-10-10
Accepted
2024-10-10 16:33:33
Documents
15
Period of Report
2024-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d881808d8k.htm   iXBRL 8-K 46231
2 EX-10.1 d881808dex101.htm EX-10.1 264436
  Complete submission text file 0001193125-24-235955.txt   558489

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blacu-20241004.xsd EX-101.SCH 4879
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20241004_def.xml EX-101.DEF 15323
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20241004_lab.xml EX-101.LAB 26121
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20241004_pre.xml EX-101.PRE 16487
17 EXTRACTED XBRL INSTANCE DOCUMENT d881808d8k_htm.xml XML 9112
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 241365577
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)